Clinical Trials

Text Size A A

E-Mail to a Friend

secret  Click to Play Audio

Head and Neck Cancer


SGX942 for Oral Mucositis in Patients With Head and Neck Cancer (20131334)
A Double-Blind, Randomized, Placebo-Controlled, Dose-Escalating, Multicenter Study Of SGX942 For The Attenuation Of Oral Mucositis In Patients Being Treated With Concomitant Chemoradiation (CRT) For The Treatment Of Squamous Cell Carcinoma Of The Head And Neck

Investigator: Jay Liao, MD;   Conditions: Head & Neck Cancer;    Status: Recruiting;   Study ID: NCT02013050